The policy, which outlines tasks for the AMA to address regarding the use of AI in healthcare, builds on a proposed a “baseline policy” the association laid out in a May report to its board of trustees. In the May report, the trade association described why it chose to use the term “augmented intelligence,” rather than the more traditional “artificial intelligence.”
“Artificial intelligence constitutes a host of computational methods that produce systems that perform tasks normally requiring human intelligence,” the report reads. “However, in healthcare a more appropriate term is ‘augmented intelligence,’ reflecting the enhanced capabilities of human clinical decision-making when coupled with these computational methods and systems.”
More articles on artificial intelligence:
AMA passes 1st AI policy
81% of healthcare execs say they’re not prepared for potential social, liability issues of AI
MIT’s new AI can track people through walls — Here’s what that means for healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
